On May 25, 2018, the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) updated their hepatitis C virus (HCV) screening and treatment recommendations to focus on groups most at-risk for HCV, including pregnant women who previously were not regularly screened, people who inject drugs, men who have sex with men and individuals who are incarcerated.

We applaud these organizations for formalizing recommendations that emphasize the importance of testing these communities and treating virtually all patients with the virus.

Read and download the updated recommendations here or on our website, under Clinician Resources.